Process for the preparation of (3R,3aS,6aR)-hexahydrofuro [2,3-b] furan-3-yl (1S,2R)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarba mate

Details for Australian Patent Application No. 2009286619 (hide)

Owner Tibotec Pharmaceuticals

Inventors Wigerinck, Piet Tom Bert Paul; Surleraux, Dominique Louis Nestor Ghislain; Verschueren, Wim Gaston; De Kock, Herman Augustinus; Aelterman, Wim Albert Alex

Agent Shelston IP

Pub. Number AU-A-2009286619

PCT Pub. Number WO2010/023322

Priority 08163383.6 01.09.08 EP

Filing date 1 September 2009

Wipo publication date 4 March 2010

International Classifications

C07D 493/04 (2006.01) Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system

Event Publications

10 March 2011 PCT application entered the National Phase

  PCT publication WO2010/023322 Priority application(s): WO2010/023322

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009286624-Method for obtaining oligonucleotide aptamers and uses thereof

2009286617-Plants having enhanced yield-related traits and a method for making the same